A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Hydrocodone | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Magnesium sulfate | The therapeutic efficacy of Chloral hydrate can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Chloral hydrate may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Mirtazapine | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Orphenadrine | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Pramipexole | Chloral hydrate may increase the sedative activities of Pramipexole. |
| Ropinirole | Chloral hydrate may increase the sedative activities of Ropinirole. |
| Rotigotine | Chloral hydrate may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Chloral hydrate. |
| Suvorexant | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Thalidomide | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Chloral hydrate. |
| Sodium oxybate | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dicoumarol | The protein binding of Dicoumarol can be decreased when combined with Chloral hydrate. |
| Phenindione | The protein binding of Phenindione can be decreased when combined with Chloral hydrate. |
| Warfarin | The protein binding of Warfarin can be decreased when combined with Chloral hydrate. |
| Phenprocoumon | The protein binding of Phenprocoumon can be decreased when combined with Chloral hydrate. |
| Acenocoumarol | The protein binding of Acenocoumarol can be decreased when combined with Chloral hydrate. |
| 4-hydroxycoumarin | The protein binding of 4-hydroxycoumarin can be decreased when combined with Chloral hydrate. |
| Coumarin | The protein binding of Coumarin can be decreased when combined with Chloral hydrate. |
| (R)-warfarin | The protein binding of (R)-warfarin can be decreased when combined with Chloral hydrate. |
| Ethyl biscoumacetate | The protein binding of Ethyl biscoumacetate can be decreased when combined with Chloral hydrate. |
| Fluindione | The protein binding of Fluindione can be decreased when combined with Chloral hydrate. |
| Clorindione | The protein binding of Clorindione can be decreased when combined with Chloral hydrate. |
| Diphenadione | The protein binding of Diphenadione can be decreased when combined with Chloral hydrate. |
| Tioclomarol | The protein binding of Tioclomarol can be decreased when combined with Chloral hydrate. |
| (S)-Warfarin | The protein binding of (S)-Warfarin can be decreased when combined with Chloral hydrate. |
| Furosemide | The risk or severity of adverse effects can be increased when Furosemide is combined with Chloral hydrate. |
| Ethanol | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Seproxetine. |
| Levomilnacipran | Chloral hydrate may decrease the excretion rate of Levomilnacipran which could result in a higher serum level. |
| Indalpine | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Alaproclate. |
| Benzatropine | Benzatropine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Disopyramide | Disopyramide may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Chloral hydrate. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Chloral hydrate. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Chloral hydrate. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Chloral hydrate. |
| Propantheline | Propantheline may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Dicyclomine | Dicyclomine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Chloral hydrate. |
| Tolterodine | Tolterodine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Flavoxate | Flavoxate may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Tiotropium | Tiotropium may decrease the excretion rate of Chloral hydrate which could result in a higher serum level. |
| Pizotifen | The risk or severity of CNS depression can be increased when Chloral hydrate is combined with Pizotifen. |
| Fesoterodine | Chloral hydrate may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
| Aclidinium | Chloral hydrate may decrease the excretion rate of Aclidinium which could result in a higher serum level. |
| Trimebutine | Chloral hydrate may decrease the excretion rate of Trimebutine which could result in a higher serum level. |
| Dosulepin | The risk or severity of CNS depression can be increased when Chloral hydrate is combined with Dosulepin. |
| Imidafenacin | Chloral hydrate may decrease the excretion rate of Imidafenacin which could result in a higher serum level. |
| Propiverine | Chloral hydrate may decrease the excretion rate of Propiverine which could result in a higher serum level. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Chloral hydrate. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Chloral hydrate. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Chloral hydrate. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Chloral hydrate. |
| Zopiclone | The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Chloral hydrate. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Chloral hydrate. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Chloral hydrate. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Chloral hydrate. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Chloral hydrate. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Chloral hydrate. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Chloral hydrate. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Chloral hydrate. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Chloral hydrate. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Chloral hydrate. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Chloral hydrate. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Chloral hydrate. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Chloral hydrate. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Chloral hydrate. |